Legend Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-275
Closed -$296K 40
2025
Q4
$296K Sell
275
-25
-8% -$23.9K 0.18% 34
2025
Q3
$229K Hold
300
0.14% 38
2025
Q2
$234K Hold
300
0.16% 36
2025
Q1
$248K Hold
300
0.18% 34
2024
Q4
$232K Hold
300
0.16% 32
2024
Q3
$266K Sell
300
-50
-14% -$45K 0.18% 32
2024
Q2
$317K Hold
350
0.22% 35
2024
Q1
$272K Hold
350
0.2% 34
2023
Q4
$204K Sell
350
-19
-5% -$11.1K 0.16% 32
2023
Q3
$198K Hold
369
0.17% 39
2023
Q2
$173K Sell
369
-100
-21% -$41.9K 0.14% 37
2023
Q1
$161K Sell
469
-69
-13% -$23.3K 0.14% 37
2022
Q4
$197K Sell
538
-100
-16% -$35.5K 0.17% 39
2022
Q3
$206K Hold
638
0.19% 33
2022
Q2
$207K Buy
+638
New +$192K 0.21% 29

Other funds holding LLY

Legend Financial Advisors's LLY Position: Q1 2026 in Review

Legend Financial Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 275 shares — an estimated $296K sold.

Legend Financial Advisors first reported a position in LLY in Q2 2022 and held it in 15 quarters. The position peaked at $317K in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Legend Financial Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Legend Financial Advisors sold 275 Eli Lilly shares in Q1 2026, an estimated $296K.
  • Legend Financial Advisors first reported a position in Eli Lilly in Q2 2022 and held it in 15 quarters.
  • Legend Financial Advisors's Eli Lilly position peaked at $317K in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Legend Financial Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.